Navigation Links
The Ensign Group, Inc. Reports Third Quarter 2008 Earnings; Reaffirms 2008 Guidance
Date:10/30/2008

Conference Call and Webcast Scheduled for October 31, 2008 at 11:30 am ET

MISSION VIEJO, Calif., Oct. 30 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services and assisted living companies, today reported record results for the third quarter of fiscal year 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO)

Third Quarter Highlights Include:

-- Total revenue was a record $116.3 million, up 11.8% over the third

quarter of 2007; and organic revenue was $113.5 million, up 9.8% over

the prior year;

-- Skilled revenue for the quarter increased 24.6% over the prior year to

$51.4 million, as skilled mix improved 460 basis points to 46.3%;

-- EBITDA improved 45.6% in the quarter to $14.2 million, compared to

$9.7 million in 2007;

-- Consolidated net income for the quarter was a record $6.8 million,

compared to $4.5 million the year before, an overall improvement of

52.2%; and

-- The Company had $56.4 million in cash at quarter end, which included

$35.6 million in year-to-date cash flow from operations, a 224.0%

increase over cash flow from operations for the first nine months of

2007 of $11.0 million.

Operating Results

Commenting on the results, Ensign President and Chief Executive Officer Christopher Christensen said, "Despite the economic downturn, we are pleased to report that we have quickly adjusted to achieve the highest revenue and earnings in the third quarter we've ever posted."

'/>"/>
SOURCE The Ensign Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. The Ensign Group, Inc. Acquires Four Skilled Nursing Facilities
2. The Ensign Group Schedules 2008 Third Quarter Earnings Call for Friday, October 31, 2008
3. The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance
4. The Ensign Group Schedules 2008 Second Quarter Earnings Call for Thursday, August 7, 2008
5. The Ensign Group to Present at the FBR Capital Markets 12th Annual Spring Investor Conference on May 29th
6. The Ensign Group, Inc. Acquires Utah Skilled Nursing Facility
7. The Ensign Group, Inc. Reports First Quarter 2008 Earnings
8. The Ensign Group Schedules 2008 First Quarter Earnings Call for Thursday, May 8, 2008
9. The Ensign Group, Inc. Reports Fourth Quarter 2007 Earnings
10. The Ensign Groups Year-End Conference Call Scheduled for Friday, March 7, 2008
11. The Ensign Group Establishes $50 Million Credit Facility with GE Healthcare Financial Services
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:More women with early-stage breast cancer choosing double mastectomies 2Health News:HealthMapRx, Mirixa and the City of Asheville Announce New Partnership to Improve Health & Healthcare Savings of Beneficiaries With Chronic Diseases 2Health News:HealthMapRx, Mirixa and the City of Asheville Announce New Partnership to Improve Health & Healthcare Savings of Beneficiaries With Chronic Diseases 3Health News:Nuvilex, Inc. Announces Investor Conference Call and Open House 2Health News:Nuvilex, Inc. Announces Investor Conference Call and Open House 3Health News:Children's Home + Aid Faces Revenue Shortfall 2Health News:Lifeclinic Names New Executive Vice President as its Presence in Non-Retail Wellness Sector Grows 2Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 2Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 3Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 4Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 5
Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 1The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 2The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 3The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 4Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 1Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 1Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 3
Other Medicine Technology:Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 2Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 3Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 4Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 2CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 3CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 4CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 6CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 7CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 8CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 9CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 10